Fellowship · Houston, TX
Sponsored by Baylor College of Medicine
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers.
Nature · 2025 · 225 citations · David Steffin, Malcolm Brenner, Andras Heczey
Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children.
The New England journal of medicine · 2025 · 187 citations · Rachel Rau
The Children's Oncology Group Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent, and Young Adult Cancers: A Review.
JAMA oncology · 2025 · 126 citations · Monica Gramatges
Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial.
Nature medicine · 2025 · 143 citations · Michelle Choe
Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 326 citations · Gary Myers
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.
Nature medicine · 2024 · 168 citations · Lindsay Kilburn, Patricia Baxter
ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 90 citations · Kevin Bielamowicz
International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults.
Blood · 2022 · 213 citations · Kenneth McClain